Aligos Therapeutics Ownership | Who Owns Aligos Therapeutics?


OverviewForecastRevenueFinancialsChart

Aligos Therapeutics Ownership Summary


Aligos Therapeutics is owned by 3.82% institutional investors, 10.37% insiders, and 85.81% retail investors. Woodline partners lp is the largest institutional shareholder, holding 4.52% of ALGS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.40% of its assets in Aligos Therapeutics shares.

ALGS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAligos Therapeutics3.82%10.37%85.81%
SectorHealthcare Stocks 42.53%10.81%46.67%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Woodline partners lp468.20K4.52%$4.59M
Deep track capital, lp444.11K4.29%$4.35M
Alyeska investment group412.00K3.98%$4.04M
Sio capital management335.94K3.25%$3.29M
Readystate asset management lp203.11K1.96%$1.99M
Vanguard group171.69K1.66%$1.68M
Adage capital partners gp140.00K1.35%$1.37M
Baker bros. advisors lp83.06K0.80%$813.94K
Hhlr advisors76.25K0.74%$747.22K
Lpl financial55.12K0.53%$540.18K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sio capital management335.94K0.83%$3.29M
Deep track capital, lp444.11K0.12%$4.35M
Readystate asset management lp203.11K0.08%$1.99M
Woodline partners lp468.20K0.02%$4.59M
Hhlr advisors76.25K0.02%$747.22K
Alyeska investment group412.00K0.01%$4.04M
Baker bros. advisors lp83.06K0.01%$813.94K
Quest partners6.77K0.00%$66.37K
Golden state wealth management2.67K0.00%$26.20K
Northcrest asset manangement10.00K0.00%$98.40K

Top Buyers

HolderShares% AssetsChange
Readystate asset management lp203.11K0.08%66.33K
Vanguard group171.69K-31.91K
Two sigma investments, lp38.99K0.00%26.92K
Lpl financial55.12K0.00%25.02K
Ubs group16.18K-13.44K

Top Sellers

HolderShares% AssetsChange
Armistice capital---7.26M
Ecor1 capital---6.39M
Versant venture management---1.46M
Opaleye management---1.26M
Pivotal bioventure partners investment advisor---743.22K

New Positions

HolderShares% AssetsChangeValue
Virtu financial12.31K0.00%12.31K$4.00K
Northcrest asset manangement10.00K0.00%10.00K$98.40K
Rockefeller capital management1.00K-1.00K$9.80K
Global retirement partners800.000.00%800.00$7.84K
Barclays15.00-15.00$147.00

Sold Out

HolderChange
Qube research-2.00
Fmr-10.00
Nelson, van denburg & campbell wealth management group-80.00
Spire wealth management-200.00
Advisor group-220.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20259-75.68%395,786-85.37%30.56%6-66.67%--100.00%
Jun 30, 2025375.71%2,706,888-15.60%261.80%19-9.52%8-
Mar 31, 2025352.94%3,295,608103.61%395.89%20-9.09%8166.67%
Dec 31, 20241-80---1---
Jun 30, 202448-5.88%47,289,2312.33%300.59%17-29.17%13160.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv97.53K1.40%-2.13K
Vanguard US Total Market Shares ETF52.80K0.86%-
Vanguard Institutional Extnd Mkt Idx Tr42.24K0.61%3.06K
Schwab US Small-Cap ETF™25.39K0.37%35.00
Fidelity Extended Market Index23.08K0.33%9.17K
Fidelity Series Total Market Index8.20K0.12%4.43K
Fidelity Total Market Index7.60K0.11%-16.00
Extended Equity Market Fund K5.22K0.09%-104.00
Spartan Extended Market Index Pool F5.48K0.08%157.00
NT Ext Equity Mkt Idx Fd - L2.87K0.05%-

Recent Insider Transactions


DateNameRoleActivityValue
Oct 25, 2023Nuechterlein Carole Buy$6.00M
Oct 25, 2023Nuechterlein Carole Buy$3.00M
Oct 20, 2020Novo Holdings A/S-Buy$3.00M
Oct 20, 2020Woiwode Thomas-Buy$3.00M
Oct 20, 2020Vivo Capital VIII, LLC-Buy$7.25M

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q3--

ALGS Ownership FAQ


Who Owns Aligos Therapeutics?

Aligos Therapeutics shareholders are primarily institutional investors at 3.82%, followed by 10.37% insiders and 85.81% retail investors. The average institutional ownership in Aligos Therapeutics's industry, Biotech Stocks , is 45.24%, which Aligos Therapeutics falls below.

Who owns the most shares of Aligos Therapeutics?

Aligos Therapeutics’s largest shareholders are Woodline partners lp (468.2K shares, 4.52%), Deep track capital, lp (444.11K shares, 4.29%), and Alyeska investment group (412K shares, 3.98%). Together, they hold 12.79% of Aligos Therapeutics’s total shares outstanding.

Does Blackrock own Aligos Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Aligos Therapeutics.

Who is Aligos Therapeutics’s biggest shareholder by percentage of total assets invested?

Sio capital management is Aligos Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.83% of its assets in 335.94K Aligos Therapeutics shares, valued at 3.29M$.

Who is the top mutual fund holder of Aligos Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aligos Therapeutics shares, with 1.40% of its total shares outstanding invested in 97.53K Aligos Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools